Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.
about
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Mutational profile of primary breast diffuse large B-cell lymphoma.Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.
P2860
Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Control of translational activ ...... ivity to inhibition by PIM447.
@en
Control of translational activ ...... ivity to inhibition by PIM447.
@nl
type
label
Control of translational activ ...... ivity to inhibition by PIM447.
@en
Control of translational activ ...... ivity to inhibition by PIM447.
@nl
prefLabel
Control of translational activ ...... ivity to inhibition by PIM447.
@en
Control of translational activ ...... ivity to inhibition by PIM447.
@nl
P2093
P2860
P356
P1433
P1476
Control of translational activ ...... tivity to inhibition by PIM447
@en
P2093
Ana A Tula-Sanchez
Lingxiao Li
Praechompoo Pongtornpipat
Tara L Peters
P2860
P304
63362-63373
P356
10.18632/ONCOTARGET.11457
P407
P577
2016-09-01T00:00:00Z